Vascular Risk Factors in INPH-patients
Vascular Risk Factors, Subclinical and Manifest Vascular Disease in Patients With Idiopathic Normal Pressure Hydrocephalus
2 other identifiers
observational
860
1 country
1
Brief Summary
Idiopathic normal pressure hydrocephalus (INPH) is a treatable and a common disease of the elderly. The overall objective of this work is to describe cardio- and cerebrovascular risk factors and vascular disease in shunted INPH-patients compared to an age- and sex matched elderly population, as well as the impact of vascular risk factors and vascular co-morbidity on clinical symptoms and outcome of surgery in INPH-patients. The hypothesis is that INPH-patients have a higher level of vascular risk factors and subclinical organ damage than a normal elderly population, and that the higher the level of existing vascular risk factors, the more severe the symptoms of the hydrocephalic disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 4, 2013
CompletedFirst Posted
Study publicly available on registry
May 10, 2013
CompletedMay 29, 2013
May 1, 2013
2.5 years
April 4, 2013
May 27, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Differences in bloodpressure between INPH-patients and a sex- and agematched community based population
Enrollment of participants 2010-2012. First, all participants complete a questionnaire, second they go to their local health care center or nearby hospital for measurements and blood samples. The visit at the health care center/hospital is within a couple of months. Participants are not followed further (cross-sectional study). Analyses performed 2013-2014. First results approximately reported in the end of 2013.
More than two weeks, not longer than 6 months.
Secondary Outcomes (1)
Quality of Life in INPH-patients compared to a sex- and age-matched population.
More than 2 weeks, not longer than 6 months.
Other Outcomes (14)
Differences between INPH-patients and community based controls regarding smoking.
More than two weeks, not longer than 6 months.
Differences between INPH-patients and community based controls regarding waist-to-hip ratio.
More than 2 weeks, not longer than 6 months.
Differences between INPH-patients and community based controls regarding dietary risk score.
More than 2 weeks, not more than 6 months.
- +11 more other outcomes
Study Arms (2)
Shunted patients with INPH
Cases: Patients with normal pressure hydrocephalus who have underwent surgery. Controls: Sex- and age-matched community based controls.
Populationbased elderly.
A group of populationbased elderly, matched according to age and sex to the patients with INPH. Vascular risk factors studied.
Eligibility Criteria
Cases are all INPH-patients who underwent surgery 2008-2010 and are registered in the Swedish National Register of Hydrocephalus. Controls were found in the Swedish population indox of Umeå, and were indivdually matched to cases according to age and sex.
You may qualify if:
- INPH-patients who underwent surgery 2008-2010 and registered in the Swedish National Register of Hydrocephalus
- age \<60 and \>85
- (only for controls) living in Umeå
You may not qualify if:
- death
- a known mini mental state estimation \<23
- inability to communicate (because of severe stroke, aphasia, dementia)
- (only for controls) individuals with INPH who has not yet underwent surgery, or has not been chosen to undergo surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Umeå Universitylead
Study Sites (1)
Umeå University, Umeå University Hospital, Departement of Pharmacology and Clinical Neuroscience
Umeå, Västerbotten County, 901 87, Sweden
Related Publications (1)
Eklund SA, Israelsson H, Carlberg B, Malm J. Vascular risk profiles for predicting outcome and long-term mortality in patients with idiopathic normal pressure hydrocephalus: comparison of clinical decision support tools. J Neurosurg. 2022 Jun 10;138(2):476-482. doi: 10.3171/2022.4.JNS22125. Print 2023 Feb 1.
PMID: 35901765DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jan Malm, MD, PhD
Umeå University, Departement of Pharmacology and Clinical Neuroscience
- PRINCIPAL INVESTIGATOR
Hanna Israelsson, MD, PhD-stud
Umeå University, Departement of Pharmacology and Clinical Neuroscience
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD-student
Study Record Dates
First Submitted
April 4, 2013
First Posted
May 10, 2013
Study Start
January 1, 2010
Primary Completion
July 1, 2012
Study Completion
July 1, 2012
Last Updated
May 29, 2013
Record last verified: 2013-05